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Aims. To determine the eﬃcacy of a new distal protection method in SFA CTO interventions. Methods and Results. From June 2003
to February 2009, ninety-two consecutive, chronic total occlusions of superﬁcial femoral arteries were treated with catheter-based
intervention using a bidirectional approach. Nine of these cases were managed with our original, distal protection method, based
on symptoms, angiographic images, wire resistance, and intravascular ultrasound images. The average age was 73 years; eight
patients were male. The mean occlusion length was 17.1cm. A distal protection balloon was inserted from the retrograde sheath
in the popliteal artery and placed distal to the occluded lesion after successful wire crossing. Lesion dilatation with a balloon was
performed antegradely and debris was removed by 6Fr. guiding catheter. Debris was retrieved from all lesions, consisting mainly
of thrombus. Where we decided not to use the distal protection method, there was no distal thromboembolism. Conclusion.I n
SFA-CTO intervention, the risk of distal embolization is 10%, which can be anticipated and eliminated by the distal protection
method.
Copyright © 2009 Tomoko Kobayashi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
With the advent of distal protection devices, there has
been a dramatic reduction in complication rates caused by
dislodged thromboembolic debris released during percuta-
neous interventions [1–9]. However, as there is no speciﬁc
protection device for peripheral intervention, we developed
an original protection method for use during intervention
for high-risk, superﬁcial femoral artery (SFA) chronic total
occlusion (CTO) lesions.
The PercuSurge Guardwire (Medtronic) is an occlusive
balloon wire system on a distal 0.014-inch guidewire, which
is well suited for carotid stenting and high-risk coronary
intervention. Embolic debris dammed proximal to the
occlusion balloon is removed by catheter aspiration. One
of the problems with peripheral CTO intervention is distal
embolization. In certain cases, there is a huge amount of
plaque and thrombus inside the SFA CTO lesion. Debris
from the CTO lesion is sometimes too large to be removed
by the commercially available aspiration catheter, which is a
0.014-inch system. A second problem is that delivering the
protection devices through the CTO lesion is diﬃcult if the
lesion is long. To resolve these issues, we have developed an
original method of distal protection. In high-risk SFA-CTO
cases, we deployed a distal occlusion balloon via the popliteal
artery and used a 6Fr. large-lumen guiding catheter as an
antegrade aspiration device.
2. Methods
From June 2003 to February 2009, 126 consecutive SFA
CTO lesions were treated by catheter-based intervention. A
bidirectional approach was employed in 92 patients (73%).
In all patients, dual antiplatelet therapy was administered,
aspirin 100mg/day and ticlopidine 200mg/day, given for
more than three days before the intervention.
After successful wire crossing of the CTO lesion, an
intravascularultrasound(IVUS)studywasperformedbefore2 Cardiology Research and Practice
Table 1: Criteriafor distalprotection methods. IVUS: intravascular
ultrasound.
(i) Worsening symptoms and signs
(1) Newly onset (<6 months) of claudication
(2) Shortend walking distance
(3) Pain at rest
(4) Ulceration or gangrene of extremities
(ii) Angiographic features
(1) Contrast stain at the occlusion site
(2) Contrast defect due to thrombus
(iii) Mild resistance on the wire manipulation
Easy pass through the CTO lesion by a guidewire
(iv) IVUS ﬁndings
(1) Poorly echogenic plaque
(2) Mobile plaque
(3) Homogeneous plaque of mildly raised echogenicity
(4) Plaque with small blood ﬂow channels
full dilatation of the lesion, to determine plaque characteris-
tics. We decided to apply distal protection methods based on
the criteria in Table 1.
When the lesion is judged as carrying a high risk
of distal embolization, the popliteal artery is blocked by
an angioplasty balloon or an occlusion balloon from a
retrograde sheath. After the popliteal artery occlusion has
been established, the lesion is fully dilated with an antegrade
balloon. Debris is dammed up at the retrogradely placed
occlusion balloon. The antegrade balloon is removed and a
6Fr. guiding catheter with a Y connector is advanced into
the CTO lesion, just proximal to the retrograde protection
balloon. Aspirating with a 30mL syringe through the side
arm of the Y connector, paying attention not to suck air
through the O ring, we remove the catheter from the sheath.
Debris is checked for by ﬂushing the catheter once it has
been removed. This aspiration technique is repeated until no
f u r t h e rd e b r i si sr e m o v e d .
The IVUS study is repeated and a decision is made
whether stent deployment is required or not. We select the
stent size and length based on IVUS ﬁndings. The landing
position of the stent is selected as the portion where there
is little plaque and therefore a low risk of edge dissection;
we mark the position of the IVUS probe using ﬂuoroscopy
to localize the site precisely. The stent is delivered in an
antegradefashion.Tocheckthedistalstentposition, contrast
agent is injected through the wire lumen of the retrograde
occlusion balloon. After stent deployment and optimization
byballoondilatation,debrisaspirationisperformedthrough
the antegrade sheath with the guiding catheter. When no
distal debris remains, the occlusion balloon is deﬂated and
ﬁnal injection via the proximal sheath is performed.
3.A CaseExample
An eighty-two-year-old male with severe intermittent clau-
dication of the left foot, Fontaine classiﬁcation stage IIb, had
diabetes mellitus that was controlled by oral agents. He was
a current smoker. Arterial Doppler examination revealed an
ankle-brachial index (ABI) of 1.05 on the right and 0.71 on
the left. Diagnostic angiography showed complete occlusion
(occlusion length 12cm) of the left SFA and reconstitution
above the knee at the popliteal artery, which was ﬁlled by
collaterals (Figure 1).
4. Procedure
For the retrograde approach, a 6Fr. sheath was inserted
into the left popliteal artery with ultrasound guidance to
prevent venous puncture. The patient was rolled over from
the prone position to the supine position. A 6Fr. sheath
was inserted into the left femoral artery in the antegrade
direction.Throughthesheathinthepoplitealartery,a0.018-
inch guidewire (Treasure 12g, Asahi Intecc) was advanced
into the left SFA. The wire crossed the CTO lesion relatively
quickly and emerged from the femoral sheath. The wire was
exchanged for a 0.014-inch guidewire using a microcatheter
(Transit, Cordis), and we examined the lesion by IVUS
(Intrafocus, Terumo). IVUS imaging showed that the CTO
lesion was ﬁlled with plaque of mixed echogenicity (Figures
2 and 3), implying the presence of thrombus. Based on
these results, we decided to use distal protection. A 6 ×
40mm PTA balloon catheter (Opera, Abbott vascular) was
inserted via the popliteal sheath and dilated at 3 atmospheres
to establish distal arterial occlusion. After predilating with
a6× 80mm PTA balloon catheter (Submarine, INVAtec)
from the left femoral sheath (Figure 4), a 6Fr. 55cm straight
guiding catheter (Autobahn, inner diameter 0.073-inch,
Nipro) was advanced and plaque and thrombus were sucked
from the vessel (Figure 5). We deployed an 8 × 66mm
self-expanding stent (Wall, Boston Scientiﬁc) and after
dilatation was performed with a 6 × 80mm balloon at 5
atmospheres (Figure 6). After we sucked up debris three
times (Figure 7), we checked for the absence of debris at
the distal end of the CTO lesion by injecting dye through
the tip of the lumen of the occlusion balloon (Figure 8).
Final angiography, once the protective balloon was deﬂated,
showed good distal runoﬀ without embolism (Figure 9).
Histopathological examination of the debris showed ﬁbrin
thrombus with inﬂammatory cells (Figures 10 and 11). After
intervention, the ABI on the left rose to 0.91 and symptoms
were relieved.
5. Results
In nine of 92 cases (9.8%), the distal protection method was
applied in management of SFA CTO procedures.
Table 2 shows the characteristics of these nine patients,
thesitesusedforinterventionandthelengthsoftheoccluded
lesions. The average age was 73 years (62–83) and eight
(89%) were male.
Two patients (nos. 2 and 4) showed critical limb
ischemia. The retrograde approach site was the popliteal
artery. The average CTO length was 17.1cm (6–24cm).
Table 3 shows the interventional procedures and acute
results. In six procedures, distal protection was performedCardiology Research and Practice 3
Figure 1: Preprocedural angiogram showed occlusion of the
superﬁcial femoral artery. The contrast agent was hazy at the distal
end.
Figure 2: An IVUS image showed that the lesion was occupied with
mixed plaque.
using percutaneous transluminal angioplasty balloons, and
in the other case, an occlusion balloon was used. All
interventions (balloon angioplasty: 1, self-expanding stent:
8) were technically successful. Debris was retrieved from
all lesions, consisting mainly of thrombus. In three cases
(33%), distal embolism occurred to the arteries below the
knee. Distally embolized thrombi were removed using a 5Fr.
Figure 3: On IVUS the plaque consisted of two layers. The center
of the plaque, a layer of low echogenicity, was mobile.
Figure 4: The distal PTA balloon was inserted using a retrograde
approach and inﬂated to protect against thromboemboli. The
proximal PTA balloon was inserted antegrade and used to dilate the
occlusion site.
catheter and a monorail aspiration catheter designed for
coronary artery interventions (TVAC, Nipro). After further
repeated aspiration, ﬂow to the toe recovered completely
and features of limb ischemia did not appear. However,
there was no case in which distal emboli occurred (0/83)
after we decided that distal protection was not required. An
inhospital, major adverse event occurred in one case (patient
no. 2). As he had gangrene below his right ankle prior to
admission, we could not avoid amputation of his right leg
below the knee, one month after intervention. In all other
patients, both symptoms and ABI improved.4 Cardiology Research and Practice
Table 2: Patient characteristics, approach site and occlusion length. Pt: patient, F: female, M: male, HT: hypertention, DM: diabetes, IC:
intermittent claudication, CLI: critical limb ischemia, Rt: right, Lt: left, SFA: superﬁcial femoral artery, FA: femoral artery, PA: popliteal
artery.
Pt. no Age sex Risk factor Diagnosis
(Fontaine)
Target SFA Antegrade-
approach
Petrograde-
approach
Occlusion
length
18 3 F H T IC (IIb) Rt Lt FA 6F Rt PA 6F 16.5cm
2 74 M HT, DM, smoking CLI Rt Rt FA 7F Rt PA 4F 15cm
3 82 M DM, smoking IC (IIb) Lt Lt FA 6F Lt PA 6F 12cm
4 72 M HT, smoking CLI Rt Lt FA 6F Rt PA 4F 17cm
5 62 M HT, smoking IC (IIa) Lt Lt FA 6F Lt PA 6F 23cm
6 83 M HT, smoking IC (IIb) Lt Lt FA 6F Lt PA 4F 18cm
7 70 M HT, smoking IC (IIb) Rt Rt FA 6F Rt PA 6F 6cm
8 65 M HT, smoking IC (IIb) Rt Lt FA 6F Rt PA 6F 22cm
9 62 M HT, DM, Dyslipidemia IC (IIb) Rt Rt FA 6F Rt PA 6F 24cm
Table 3: Procedure and results. ABI: ankle and brachial index.
Pt. no Protection
device
Intervention
device
Success ABI (Pre–post) Debris Distal embolism Pathology of debris
1 PTA balloon Balloon yes 0.6–0.83 + − Thrombus with hyalinization
and inﬂammatory cells
2 PTA balloon Stent yes 0–none + − Fibrin thrombus
3 PTA balloon Stent yes 0.71–0.91 + − Fibrin thrombus with
inﬂammatory cells
4 PTA balloon Stent yes 0–1.01 + − Fresh thrombus
5 Occlusion
catheter Stent yes 0.57–0.9 + − Fibrin thrombus with
neutrophils
6 PTA balloon Stent yes 0–1.21 + + Fibrin thrombus
7 Occlusion
catheter Stent yes 0.54–1.34 + + Fibrin thrombus
8 Occlusion
catheter Stent yes 0.76–1.04 + + Fibrin thrombus
9 PTA balloon Stent yes 0.63–1.04 + − Fibrin thrombus
Figure 5: The catheter was inserted and used to suck up debris. Figure 6: The self-expanding stents were implanted.Cardiology Research and Practice 5
Figure 7: After postdilation, debris was sucked out again.
Figure 8: We checked for the absence of debris at the distal end of
the CTO lesion by injecting dye through the tip of the lumen of the
occlusion.
6. Discussion
In cases with SFA CTO and nonacute limb ischemia, it is
diﬃcult to cross the lesion with a guidewire. However when
PTA is successful, distal embolism is rare. There have been
several published reports of distal embolization during lower
extremity intervention. The frequency of distal embolization
during thrombolytic therapy for limb-threatening ischemia
is high. One published study reported an immediate distal
thromboembolic rate of 5.3%, with similar results for
acute and subacute versus chronically occluded lesions [10].
A report on peri-operative distal embolization following
intervention for chronic iliac artery occlusion gives a rate
of 2.9% [11]. Some reports on distal embolization during
intra-arterial thrombolysis have reported rates of 8.3–24%
Figure 9: The ﬁnal angiogram showed good runoﬀ and no distal
embolism.
Figure 10: Specimen retrieved from the catheter.
[12, 13]. A report on the use of the Rotarex catheter for acute
and subacute femoro-popliteal artery occlusions indicates
that distal embolization during recanalization occurred in
24% of cases [14].
Angioplasty for acute limb ischemia carries a risk of
progressive ischemia and tissue necrosis if distal throm-
boembolism occurs. A recently occluded lesion, which
we call “unstable limb ischemia”, may be complicated by
distal embolism during intervention, which may result in
worsening ischemic symptoms. It is important to identify6 Cardiology Research and Practice
Figure 11: Hematoxylin and eosin stain of debris showed ﬁbrin
thrombus with inﬂammatory cells and immature endothelial cells.
the high-risk group. If there is a risk of distal embolization,
we believe it is best to use a method of embolic protection.
It has been reported that distal protection devices, such as
a guidewire with a balloon/ﬁlter and a balloon protection
sheath, were beneﬁcial in treating high-risk lesions of
peripheral vascular disease [15, 16]. Another report on
distal protection during femoro-popliteal atherectomy states
that the ﬁlter wires retrieved debris after atherectomy in
all cases and prevented distal embolic occlusion [17]. We
identify vulnerability of the lesion by means of symptoms,
an angiogram, resistance on wire manipulation, and IVUS
imaging. Symptoms in cases with unstable limb ischemia are
worsening claudication, cyanosis, ulceration, and gangrene
that have occurred within a few months. The angiographic
image of a case with unstable limb ischemia shows abrupt
occlusion, contrast agent oozing through, or mobile clot at
the origin of the occlusion. When we advance the wire into
thevulnerable,occludedlesion,wefeelresistanceatentrybut
the wire easily passes through the CTO lesion. IVUS images
showing mobile plaque or plaque of low echogenicity imply
that the lesion is occupied by thrombus or soft plaque. A
homogeneous, highly echogenic mass with small blood ﬂow
channels within the plaque also implies an unstable lesion.
When we detect these ﬁndings, we apply distal protection.
Because the intensity of the speckled ultrasonic signal is
positively correlated with the amount of red blood cells in
thethrombus[18]andtheechogenicityofthrombuschanges
withage,theimagesofvulnerableplaquesvary.Fourfeatures
were helpful in identifying a lesion at high-risk of distal
embolization. This occlusion method has the merit that it
is not necessary to advance the protection device through
the totally occluded lesion. We performed interventions
using a bidirectional approach in complex CTO lesions. This
method makes it easy to deliver the protection devices and
prevent distal migration of debris. Recently we chose to
use occlusion balloons via a retrograde approach, as these
balloons are cheaper than PTA balloons. In our limited
experience of just nine cases (10%) of SFA CTO with a distal
protection method, we could remove thrombotic plaque but
encountered distal emboli in 3 cases. In the remaining 83
cases in which we did not use protection, as we thought there
was a low risk of distal embolization, there was no instance
of distal embolism. This study demonstrates that more than
10% of SFA CTO catheter intervention is associated with
a risk of distal embolization. Balloon protection method
has some dead space between the occlusion balloon edge
and arterial wall. If the small plaque drops down into this
space, aspiration with the guiding catheter cannot remove
plaque completely. In our 3 cases we dropped small debris
into the distal artery below the knee and needed additional
procedures to rescue limb ischemia.
This study had several limitations. First, the sample size
is small. Second, it is diﬃcult to validate our methods used
to identify an unstable plaque. Third, our methods cannot
completely prevent distal embolism because all of the debris
cannot be aspirated through the guiding catheter.
7. Conclusion
The method of distal protection that we describe is beneﬁcial
in treating high-risk lesions that potentially contain resid-
ual thrombus, in cases with ischemic limbs. In SFA-CTO
intervention, the risk of distal embolization is 10% which
can be determined based on clinical, procedural, and IVUS
information.
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